The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study

The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

John D. McConnell, Claus G. Roehrborn, Oliver Bautista et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia

John D. McConnell, Reginald C. Bruskewitz, Patrick Walsh et al. · New England Journal of Medicine · 1998 · 1.1K citations · Full text

Medicine, Surgery, Urology +17

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

Claus G. Roehrborn, Peter Boyle, J. Curtis Nickel et al. · Urology · 2002 · 734 citations

Medicine, Endocrinology, Pharmacotherapy +11

The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT Study

Claus G. Roehrborn, Paul Siami, Jack Barkin et al. · The Journal of Urology · 2007 · 358 citations

Medicine, Pharmacotherapy, Urology +14

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia

Claus G. Roehrborn, John D. McConnell, Michael M. Lieber et al. · Urology · 1999 · 337 citations

Medicine, Surgery, Urology +16